ArticleOncology letters2023

Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study.

Haoran Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.